Advanced Therapy Medicinal Product

The Benefits of an All-Island Dedicated National Centre for ATMP Manufacturing

This paper proposes that there is a need to ensure that lreland invests adequately in Advanced Therapy Medicinal Products (ATMP) related areas to be competitive both in creating indigenous companies in this space and in attracting mobile foreign companies to locate their ATMP related activities here.

In helping to define the most effective mechanism or, structure(s) to enable this objective we solicited the views of experts in this area and studied some of the existing overseas initiatives in this space with particular reference to their scope, their ambition, their governance and the scale of funding involved.

Creating such an infrastructure will require significant investment in a) related education and training; b) further development of the single existing GMP (Good Manufacturing Practice) grade ATMP Production Facility – CCMI at NUI Galway; c) discovery science in the ATMP field; d) translational science in ATMPs and; e) ATMP clinical trial facilities.

The desired outcome of such investment would be the creation of an all island ATMP ecosystem that could facilitate and accelerate the development of indigenous ATMP focused enterprises while simultaneously increasing the attractiveness of Ireland as a location for ATMP related foreign investments.